Anticancer activities of artemisinin and its bioactive derivatives

Estrogen Mediation of Breast Tumor Formation Involves Estrogen Receptor-Dependent, as Well as Independent, Genotoxic Effects

(2009) Richard Santen et al.   Annals of the New York Academy of Sciences

Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo

(2009) Hua Chen et al.   ANTI-CANCER DRUGS

Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1α and P-glycoprotein overexpression

(2009) C Riganti et al.   BRITISH JOURNAL OF PHARMACOLOGY

Pharmacokinetics and Pharmacodynamics of Endoperoxide Antimalarials

(2009) Anirudh Gautam et al.   CURRENT DRUG METABOLISM

Stress-Activated MAP Kinase Cascades in Cellular Senescence

(2009) Junichi Maruyama et al.   CURRENT MEDICINAL CHEMISTRY

Chemokine Receptors as Targets for Cancer Therapy

(2009) Xuesong Wu et al.   CURRENT PHARMACEUTICAL DESIGN

Endocrine therapy for the treatment of postmenopausal women with breast cancer

(2009) Seema Harichand-Herdt et al.   Expert Review of Anticancer Therapy

Master regulation of bile acid and xenobiotic metabolism via the FXR, PXR and CAR trio

(2009) Salvatore Modica   Frontiers in Bioscience-Landmark

Understanding the Epidemiology, Natural History, and Key Pathways Involved in Prostate Cancer

(2009) E. David Crawford   UROLOGY

Induction of P-glycoprotein expression and function in human intestinal epithelial cells (T84)

(2008) I.S. Haslam et al.   BIOCHEMICAL PHARMACOLOGY

Transferrin receptor-dependent cytotoxicity of artemisinin–transferrin conjugates on prostate cancer cells and induction of apoptosis

(2008) Ikuhiko Nakase et al.   CANCER LETTERS

Artesunate Derived from Traditional Chinese Medicine Induces DNA Damage and Repair

(2008) P. C.H. Li et al.   CANCER RESEARCH

Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells

(2008) S. N. Sundar et al.   CARCINOGENESIS

Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of Action

(2008) J. Hou et al.   CLINICAL CANCER RESEARCH

Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics

(2008) A. C. Mita et al.   CLINICAL CANCER RESEARCH

Artemisinin reduces human melanoma cell migration by down-regulating αVβ3 integrin and reducing metalloproteinase 2 production

(2008) Elisabetta Buommino et al.   INVESTIGATIONAL NEW DRUGS

Indole-3-carbinol Inhibits Sp1-Induced Matrix Metalloproteinase-2 Expression To Attenuate Migration and Invasion of Breast Cancer Cells

(2008) Wen-Chun Hung et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Artemisinin Blocks Prostate Cancer Growth and Cell Cycle Progression by Disrupting Sp1 Interactions with the Cyclin-dependent Kinase-4 (CDK4) Promoter and Inhibiting CDK4 Gene Expression

(2008) Jamin A. Willoughby et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Androgen receptor knockout and knock-in mouse models

(2008) S Kerkhofs et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Apoptotic Signaling Pathways as a Target for the Treatment of Liver Diseases

(2008) J. Mauriz et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY

New insights into the classical and non-classical actions of estrogen: Evidence from estrogen receptor knock-out and knock-in mice

(2008) Melissa A. McDevitt et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Dihydroartemisinin Potentiates the Cytotoxic Effect of Temozolomide in Rat C6 Glioma Cells

(2008) Xiao-Jia Huang et al.   PHARMACOLOGY

ERβ in breast cancer—Onlooker, passive player, or active protector?

(2008) Emily M. Fox et al.   STEROIDS

Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation

(2007) J-X Wang et al.   BRITISH JOURNAL OF PHARMACOLOGY